Sales to outside customers increased significantly to 156,851 million yen
(up 14.8% year-on-year).
Sales of "Melano CC" remained brisk thanks to strong sales of the enzyme face wash marketed under this brand. "Hadalabo" skincare products and "Rohto V5" supplements continued to perform strongly. Sales of lip balm, which had been sluggish due to the habit of wearing masks, have recovered, too.
In addition to domestic demand, inbound demand has also been increasing. Domestic group companies also contributed to sales growth, including Rohto Nitten Co., Ltd. and Amato Pharmaceutical Products, Ltd., which has "Borraginol®" as its main product.
Segment profit (operating profit basis) increased significantly to 24,437
million yen (up 15.5% year-on-year) owing to a significant increase in
sales and improvement of the cost of sales ratio, as well as efficient
utilization of selling, general and administrative expenses.